BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26321107)

  • 1. Serum bisphenol A and progression of type 2 diabetic nephropathy: a 6-year prospective study.
    Hu J; Yang S; Wang Y; Goswami R; Peng C; Gao R; Zhou H; Zhang Y; Cheng Q; Zhen Q; Li Q
    Acta Diabetol; 2015 Dec; 52(6):1135-41. PubMed ID: 26321107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bisphenol A as a predictor of chronic kidney disease progression in primary hypertension: a 6-year prospective study.
    Hu J; Wang Y; Xiang X; Peng C; Gao R; Goswami R; Zhou H; Zhang Y; Zhen Q; Cheng Q; Yang S; Li Q
    J Hypertens; 2016 Feb; 34(2):332-7. PubMed ID: 26628110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of serum bisphenol A levels with incident chronic kidney disease risk.
    Nie H; Wang F; Zhang Y; Zhang S; Han X; Zhang X; Guo H; He M
    Sci Total Environ; 2021 Jun; 771():145401. PubMed ID: 33545483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphenol A is not associated with a 5-year incidence of type 2 diabetes: a prospective nested case-control study.
    Shu X; Tang S; Peng C; Gao R; Yang S; Luo T; Cheng Q; Wang Y; Wang Z; Zhen Q; Hu J; Li Q
    Acta Diabetol; 2018 Apr; 55(4):369-375. PubMed ID: 29387940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes.
    Ortega Moreno L; Lamacchia O; Copetti M; Salvemini L; De Bonis C; De Cosmo S; Cignarelli M; Trischitta V; Menzaghi C
    PLoS One; 2015; 10(10):e0140631. PubMed ID: 26465607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A in chronic kidney disease.
    Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
    Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of serum bisphenol A with diabetes in the Thai population, National Health Examination Survey IV, 2009.
    Aekplakorn W; Chailurkit LO; Ongphiphadhanakul B
    J Diabetes; 2015 Mar; 7(2):240-9. PubMed ID: 24720399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus.
    Yun JS; Ahn YB; Song KH; Yoo KD; Park YM; Kim HW; Ko SH
    Diabet Med; 2016 May; 33(5):639-43. PubMed ID: 26202453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study.
    Jacobson MH; Wu Y; Liu M; Attina TM; Naidu M; Karthikraj R; Kannan K; Warady BA; Furth S; Vento S; Trachtman H; Trasande L
    PLoS Med; 2020 Oct; 17(10):e1003384. PubMed ID: 33052911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis activity is associated with the prevalence of chronic kidney disease in diabetic patients.
    Asao T; Oki K; Yoneda M; Tanaka J; Kohno N
    Endocr J; 2016; 63(2):119-26. PubMed ID: 26537094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cell-free DNA and progression of diabetic kidney disease: a prospective study.
    Li X; Hu R; Luo T; Peng C; Gong L; Hu J; Yang S; Li Q
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32152147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function.
    Kim WJ; Kim SS; Bae MJ; Yi YS; Jeon YK; Kim BH; Song SH; Kim IJ; Kim YK
    J Diabetes Complications; 2014; 28(2):130-4. PubMed ID: 24438886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes.
    Hui E; Yeung CY; Lee PC; Woo YC; Fong CH; Chow WS; Xu A; Lam KS
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2169-77. PubMed ID: 25166721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Bisphenol A is an independent risk factor of hyperuricemia: A 6-year prospective study.
    Hu J; Peng C; Li J; Gao R; Zhang A; Ma L; Zhang L; Yang Y; Cheng Q; Wang Y; Luo T; Wang Z; Qing H; Yang S; Li Q
    Semin Arthritis Rheum; 2019 Feb; 48(4):644-648. PubMed ID: 29650240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
    Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
    Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
    Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
    Devetzis V; Daryadel A; Roumeliotis S; Theodoridis M; Wagner CA; Hettwer S; Huynh-Do U; Ploumis P; Arampatzis S
    PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.